Plaque and Gingivitis Evaluation of a U-Shaped Toothbrush in a 30-Day Model

NCT ID: NCT06122376

Last Updated: 2023-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-31

Study Completion Date

2023-07-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this 30 day, randomized, two group, parallel, examiner-blind clinical trial is to assess the safety and efficacy of AutoBrush® 360° U-shaped Sonic Toothbrush on plaque and gingivitis, compared to an American Dental Association (ADA) reference manual soft toothbrush. The extent of gingival abrasion and recession and oral safety will be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This single-center, randomized, controlled, examiner-blind, 30-day parallel study will consist of Screening and Baseline visits with approximately 80 subjects (age 5-65 years) who will read and sign an informed consent form and assent form, assessed for evidence of gingivitis and plaque according to the Modified Gingival Index (MGI) and the Lobene-Soparkar Modification of Turesky Modified Quigley-Hein Plaque Index (LSPI) at Baseline, Day 15 and Day 30. Gingival recession and gingival abrasion will be measured at all visits. Subjects will be randomly assigned to one of two groups twice daily brushing with ADA accepted fluoride toothpaste and 1) two-minute brushing with ADA reference standard manual toothbrush, or 2) 30-second brushing with AutoBrush® 360° U-shaped Sonic Toothbrush.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Plaque Induced Gingivitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Examiner-blind only, subjects received treatment assignment and instructions in a room separate from the examiner and exam area.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

U-shaped power toothbrush

U-shaped power toothbrush with fluoride toothpaste

Group Type EXPERIMENTAL

U-shaped Power Toothbrush

Intervention Type DEVICE

Twice daily brushing for 30 seconds with fluoride toothpaste

Manual Toothbrush

soft manual toothbrush with fluoride toothpaste

Group Type PLACEBO_COMPARATOR

Soft Manual Toothbrush

Intervention Type DEVICE

Twice daily brushing for two minutes with fluoride toothpaste

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

U-shaped Power Toothbrush

Twice daily brushing for 30 seconds with fluoride toothpaste

Intervention Type DEVICE

Soft Manual Toothbrush

Twice daily brushing for two minutes with fluoride toothpaste

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* generally healthy males and females at least 5 to 65 years of age.
* If under age 18, willing to provide assent to participate and consent from a parent or legal guardian prior to being entered into the study; If 18 years of age or older, is able to read, sign and receive a copy of the signed informed consent form.
* regular manual toothbrush users and able to brush their own teeth on a daily basis.
* In good health based on medical history review by the investigator.
* willing to refrain from all oral hygiene for approximately 12-16 hours prior to each study visit and discontinue eating and drinking for approximately 30 minutes prior to each study visit, with the exception of sips of water.
* Have a minimum of 18 natural teeth, in the adult dentition, with scorable facial and lingual surfaces. If under the age of 12, must have at least 12 fully erupted teeth, primary or permanent teeth. Partially erupted permanent teeth and primary teeth that are loose or in process of exfoliation will not be included in the tooth count. Teeth that are grossly carious, orthodontically banded, exhibiting general cervical abrasion and/or enamel abrasion, \> 2 mm gingival recession will not be included in the tooth count.
* Present with a gingival index score ≥ 1.75 according to the Modified Gingival Index at Baseline, a plaque index score \> 1.80 according to the Lobene-Soparkar Modification of the Turesky Modification of the Quigley-Hein Plaque Index, following a 12 to 16-hour plaque accumulation period at Baseline.
* willing and able to refrain from dental treatment during the course of the study, except on an emergency basis.

Exclusion Criteria

* history of adverse effects, oral soft or hard tissue sensitivity, to any ingredient in the test materials.
* Self-reported serious medical conditions.
* Self-reported as pregnant or nursing.
* Under treatment for a heart condition requiring use of pacemaker.
* Have any condition, in the opinion of the investigator, that would place the subject at increased risk or preclude the subject's full compliance with or completion of the study?
* Require antibiotic premedication prior to dental procedures.
* Have had antibiotic, anti-inflammatory, anti-coagulant medication or chemotherapeutic antiplaque/antigingivitis therapy within 30 days of screening exams.
* participated in any study involving oral care products, concurrently or within the 30 days of screening exams.
* Unwilling to discontinue use of other oral hygiene products for the duration of the study.
* Present use of any tobacco products.
* Presence of severe periodontal disease or being actively treated for periodontal disease.
* Have grossly carious, fully crowned, or extensively restored teeth.
* Have orthodontic appliances, peri/oral piercings, or removable partial dentures.
* Have significant oral soft tissue pathology based on a visual examination.
Minimum Eligible Age

5 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lander Enterprises, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeffery L Milleman

Role: PRINCIPAL_INVESTIGATOR

Salus Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Salus Research, Inc

Fort Wayne, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AB-GBP-2023-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.